39. Matta H, Mazzacurati L, Schamus S, Yang T, Sun Q, et al. (2007) Kaposi’s Sarcoma-associated Herpesvirus (KSHV) Oncoprotein K13 Bypasses TRAFs and Directly Interacts with the IkappaB Kinase Complex to Selectively Activate NF-kappaB without JNK Activation. J Biol Chem 282: 24858–24865. 40. Zhao J, Punj V, Matta H, Mazzacurati L, Schamus S, et al. (2007) K13 Blocks KSHV Lytic Replication and Deregulates vIL6 and hIL6 Expression: a Model of Lytic Replication Induced Clonal Selection in Viral Oncogenesis. PLoS ONE 2: e1067. 41. Matta H, Punj V, Schamus S, Mazzacurati L, Chen AM, et al. (2008) A nuclear role for Kaposi’s sarcoma-associated herpesvirus-encoded K13 protein in gene regulation. Oncogene 27: 5243–5253. 42. Chaudhary PM, Jasmin A, Eby MT, Hood L (1999) Modulation of the NF- kappa B pathway by virally encoded death effector domains-containing proteins. Oncogene 18: 5738–5746. 43. Kumar A, Eby MT, Sinha S, Jasmin A, Chaudhary PM (2001) Ectodermal dysplasia receptor activates the nuclear factor kappa B, c-Jun N-terminal kinase and cell death pathways and binds to ectodysplasin A. J Biol Chem 276: 2668–2677. 44. Matta H, Chaudhary PM (2004) Activation of alternative NF-kappa B pathway by human herpes virus 8-encoded Fas-associated death domain-like IL-1 beta- converting enzyme inhibitory protein (vFLIP). Proc Natl Acad Sci U S A 101: 9399–9404. 45. Matta H, Sun Q, Moses G, Chaudhary PM (2003) Molecular genetic analysis of human herpes virus 8-encoded viral FLICE inhibitory protein-induced NF- kappaB activation. Journal of Biological Chemistry 278: 52406–52411. 46. Chen ZJ (2005) Ubiquitin signalling in the NF-kappaB pathway. Nat Cell Biol 7: 758–765. 47. Muzio M, Natoli G, Saccani S, Levrero M, Mantovani A (1998) The human toll signaling pathway: divergence of nuclear factor kappaB and JNK/SAPK activation upstream of tumor necrosis factor receptor-associated factor 6 (TRAF6). J Exp Med 187: 2097–2101. 48. Matta H, Surabhi RM, Zhao J, Punj V, Sun Q, et al. (2007) Induction of spindle cell morphology in human vascular endothelial cells by human herpesvirus 8- encoded viral FLICE inhibitory protein K13. Oncogene 26: 1656–1660. 49. Matta H, Gopalakrishnan R, Punj V, Yi H, Suo Y, et al. (2011) A20 is induced by Kaposi sarcoma-associated herpesvirus-encoded viral FLICE inhibitory protein (vFLIP) K13 and blocks K13-induced nuclear factor-kappaB in a negative feedback manner. J Biol Chem 286: 21555–21564. 50. Bottero V, Kerur N, Sadagopan S, Patel K, Sharma-Walia N, et al. (2011) Phosphorylation and polyubiquitination of transforming growth factor beta- activated kinase 1 are necessary for activation of NF-kappaB by the Kaposi’s sarcoma-associated herpesvirus G protein-coupled receptor. J Virol 85: 1980–1993. 51. Shembade N, Ma A, Harhaj EW (2010) Inhibition of NF-kappaB signaling by A20 through disruption of ubiquitin enzyme complexes. Science 327: 1135–1139. 52. Suzuki S, Singhirunnusorn P, Mori A, Yamaoka S, Kitajima I, et al. (2007) Constitutive activation of TAK1 by HTLV-1 tax-dependent overexpression of TAB2 induces activation of JNK-ATF2 but not IKK-NF-kappaB. J Biol Chem 282: 25177–25181. 53. Ninomiya-Tsuji J, Kajino T, Ono K, Ohtomo T, Matsumoto M, et al. (2003) A resorcylic acid lactone, 5Z-7-oxozeaenol, prevents inflammation by inhibiting the catalytic activity of TAK1 MAPK kinase kinase. J Biol Chem 278: 18485–18490. 54. Seymour RE, Hasham MG, Cox GA, Shultz LD, Hogenesch H, et al. (2007) Spontaneous mutations in the mouse Sharpin gene result in multiorgan K13 Activates NFkB Independent of TRAF6/TAK1/LUBAC inflammation, immune system dysregulation and dermatitis. Genes Immun 8: 416–421. 55. Rahighi S, Ikeda F, Kawasaki M, Akutsu M, Suzuki N, et al. (2009) Specific recognition of linear ubiquitin chains by NEMO is important for NF-kappaB activation. Cell 136: 1098–1109. 56. Brummelkamp TR, Nijman SM, Dirac AM, Bernards R (2003) Loss of the cylindromatosis tumour suppressor inhibits apoptosis by activating NF-kappaB. Nature 424: 797–801. 57. Niu J, Shi Y, Iwai K, Wu ZH (2011) LUBAC regulates NF-kappaB activation upon genotoxic stress by promoting linear ubiquitination of NEMO. Embo J 30: 3741–3753. 58. Tokunaga F, Nakagawa T, Nakahara M, Saeki Y, Taniguchi M, et al. (2011) SHARPIN is a component of the NF-kappaB-activating linear ubiquitin chain assembly complex. Nature 471: 633–636. 59. Trompouki E, Hatzivassiliou E, Tsichritzis T, Farmer H, Ashworth A, et al. (2003) CYLD is a deubiquitinating enzyme that negatively regulates NF-kappaB activation by TNFR family members. Nature 424: 793–796. 60. Field N, Low W, Daniels M, Howell S, Daviet L, et al. (2003) KSHV vFLIP binds to IKK-{gamma} to activate IKK. J Cell Sci 116: 3721–3728. 61. Delhase M, Hayakawa M, Chen Y, Karin M (1999) Positive and negative regulation of IkappaB kinase activity through IKKbeta subunit phosphorylation. Science 284: 309–313. 62. O’Mahony A, Lin X, Geleziunas R, Greene WC (2000) Activation of the heterodimeric IkappaB kinase alpha (IKKalpha)-IKKbeta complex is di- rectional: IKKalpha regulates IKKbeta under both basal and stimulated conditions. Mol Cell Biol 20: 1170–1178. 63. Bagneris C, Ageichik AV, Cronin N, Wallace B, Collins M, et al. (2008) Crystal structure of a vFlip-IKKgamma complex: insights into viral activation of the IKK signalosome. Mol Cell 30: 620–631. 64. Shimizu A, Baratchian M, Takeuchi Y, Escors D, Macdonald D, et al. (2011) Kaposi’s sarcoma-associated herpesvirus vFLIP and human T cell lymphotropic virus type 1 Tax oncogenic proteins activate IkappaB kinase subunit gamma by different mechanisms independent of the physiological cytokine-induced path- ways. J Virol 85: 7444–7448. 65. Wu CJ, Conze DB, Li T, Srinivasula SM, Ashwell JD (2006) Sensing of Lys 63- linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected]. Nat Cell Biol 8: 398–406. 66. Hadian K, Griesbach RA, Dornauer S, Wanger TM, Nagel D, et al. (2011) NF- kappaB essential modulator (NEMO) interaction with linear and lys-63 ubiquitin chains contributes to NF-kappaB activation. J Biol Chem 286: 26107–26117. 67. Komander D, Reyes-Turcu F, Licchesi JD, Odenwaelder P, Wilkinson KD, et al. (2009) Molecular discrimination of structurally equivalent Lys 63-linked and linear polyubiquitin chains. EMBO Rep 10: 466–473. 68. Karin M, Yamamoto Y, Wang QM (2004) The IKK NF-kappa B system: a treasure trove for drug development. Nat Rev Drug Discov 3: 17–26. 69. Pasparakis M, Schmidt-Supprian M, Rajewsky K (2002) IkappaB kinase signaling is essential for maintenance of mature B cells. J Exp Med 196: 743–752. 70. Nagashima K, Sasseville VG, Wen D, Bielecki A, Yang H, et al. (2006) Rapid TNFR1-dependent lymphocyte depletion in vivo with a selective chemical inhibitor of IKKbeta. Blood 107: 4266–4273. 71. Ren H, Schmalstieg A, van Oers NS, Gaynor RB (2002) I-kappa B kinases alpha and beta have distinct roles in regulating murine T cell function. Journal of Immunology 168: 3721–3731. PLoS ONE | www.plosone.org 11 May 2012 | Volume 7 | Issue 5 | e36601